Osteopontin in HFpEF: More Than Just a Remodeling-Specific Biomarker

J Am Coll Cardiol. 2019 Jun 4;73(21):2719-2721. doi: 10.1016/j.jacc.2019.03.477.

Authors

Fadi N Salloum¹, Vinh Q Chau²

Affiliations

¹ Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia. Electronic address: fadi.salloum@vcuhealth.org.
² Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.

PMID: 31146817
DOI: 10.1016/j.jacc.2019.03.477

No abstract available

Keywords: Alport syndrome; HFpEF; OGDHL; hiPS-CM; mitochondria; osteopontin.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Biomarkers
Heart Failure*
Humans
Osteopontin
Stroke Volume
Ventricular Dysfunction, Left*

Substances

Biomarkers
Osteopontin